HLA-DRB1 Alleles and Cervical Squamous Cell Carcinoma: Experimental Study and Meta-Analysis

Human Immunology

Volumn 67, Issue 4-5, 2006, Pages 331-340

  Yang, Yuh Cheng ^a,b,c   Chang, Tzu Yang ^a   Lee, Yann Jinn ^a,c   Su, Tsung Hsien ^a,b   Dang, Ching Wen ^a   Wu, Chao Chih ^a   Liu, Hsin Fu ^a   Chu, Chen Chung ^a   Lin, Marie ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

cervical squamous cell carcinoma; Chinese; HLA DRB1; HPV; meta analysis

Indexed keywords

HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CAUCASIAN; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; META ANALYSIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TAIWAN; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, SQUAMOUS CELL; CHINA; FEMALE; GENE FREQUENCY; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 33646581717     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.03.017     Document Type: Article

References (46)

1. Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P., Ngan H.Y., Sideri M., and Pecorelli S. Carcinoma of the cervix uteri. J Epidemiol Biostat 6 (2001) -7
2. Chen C.A., and Hsieh C.Y. Recent advances and problems in primary therapy for cervical cancer in Taiwan. J Formos Med Assoc 103 (2004) 511
3. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., Scott D.R., Sherman M.E., Kurman R.J., Wacholder S., Stanton C.K., and Manos M.M. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85 (1993) 958
4. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12
5. Klein J., and Sato A. The HLA systemFirst of two parts. N Engl J Med 343 (2000) -702
6. Klein J., and Sato A. The HLA system. Second of two parts. N Engl J Med 343 (2000) -782
7. Montoya L., Saiz I., Rey G., Vela F., and Clerici-Larradet N. Cervical carcinoma. human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur J Immunogenet 25 (1998) -329
8. Krul E.J., Schipper R.F., Schreuder G.M., Fleuren G.J., Kenter G.G., and Melief C.J. HLA and susceptibility to cervical neoplasia. Hum Immunol 60 (1999) -337
9. Beskow A.H., Josefsson A.M., and Gyllensten U.B. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 93 (2001) 817
10. Madeleine M.M., Brumback B., Cushing-Haugen K.L., Schwartz S.M., Daling J.R., Smith A.G., Nelson J.L., Porter P., Shera K.A., McDougall J.K., and Galloway D.A. Human leukocyte antigen class II and cervical cancer risk. a population-based study. J Infect Dis 186 (2002) -1565
11. Wank R., and Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352 (1991) -723
12. Helland A., Borresen A.L., Kaern J., Ronningen K.S., and Thorsby E. HLA antigens and cervical carcinoma. Nature (1992) 356-23
13. Gregoire L., Lawrence W.D., Kukuruga D., Eisenbrey A.B., and Lancaster W.D. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer 57 (1994) 504
14. Nawa A., Nishiyama Y., Kobayashi T., Wakahara Y., Okamoto T., Kikkawa F., Suganuma N., Goto S., Kuzuya K., and Tomoda Y. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger. Cancer 75 (1995) 518
15. Dehaghani A.S., Amirzargar A., Farjadian S., and Ghaderi A. HLA-DQB1 alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients. Pathol Oncol Res 8 (2002) -58
16. Cuzick J., Terry G., Ho L., Monaghan J., Lopes A., Clarkson P., and Duncan I. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82 (2000) -1348
17. Maciag P.C., Schlecht N.F., Souza P.S., Franco E.L., Villa L.L., and Petzl-Erler M.L. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 9 (2000) -1183
18. Apple R.J., Becker T.M., Wheeler C.M., and Erlich H.A. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 87 (1995) -427
19. Lin P., Koutsky L.A., Critchlow C.W., Apple R.J., Hawes S.E., Hughes J.P., Toure P., Dembele A., and Kiviat N.B. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev 10 (2001) 1037
20. Terry G., Ho L., and Cuzick J. Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type. Int J Cancer 73 (1997) -651
21. Wang S.S., Wheeler C.M., Hildesheim A., Schiffman M., Herrero R., Bratti M.C., Sherman M.E., Alfaro M., Hutchinson M.L., Morales J., Lorincz A., Burk R.D., Carrington M., Erlich H.A., and Apple R.J. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia. results from a population-based study in Costa Rica. J Infect Dis 184 (2001) -1310
22. Sastre-Garau X., Loste M.N., Vincent-Salomon A., Favre M., Mouret E., de la Rochefordiere A., Durand J.C., Tartour E., Lepage V., and Charron D. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 69 (1996) -159
23. Lee H.H., Chao H.T., Ng H.T., and Choo K.B. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet 33 (1996) -371
24. Chu C.C., Lin M., Nakajima F., Lee H.L., Chang S.L., Juji T., and Tokunaga K. Diversity of HLA among Taiwan's indigenous tribes and the Ivatans in the Philippines. Tissue Antigens (2001) 58-9
25. Voorter C.E., Rozemuller E.H., de Bruyn-Geraets D., van der Zwan A.W., Tilanus M.G., and van den Berg-Loonen E.M. Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 49 (1997) 471
26. Donner H., Rau H., Walfish P.G., Braun J., Siegmund T., Finke R., Herwig J., Usadel K.H., and Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82 (1997) -143
27. Lancaster A., Nelson M.P., Single R.M., Meyer D., and Thomson G. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. In: Altman R.B., et al. (Ed). Pacific Symposium on Biocomputing 8 (2003), World Scientific, Singapore 514
28. Guo S.W., and Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48 (1992) -361
29. Lee Y.J., Chen M.R., Chang W.C., Lo F.S., and Huang F.Y. A freely available statistical program for testing associations. (freely available on request to yannlee@ms2.mmh.org.tw). MD Comput 15 (1998) -327
30. Svejgaard A., and Ryder L.P. HLA and disease associations. detecting the strongest association. Tissue Antigens (1994) 43-18
31. Thakkinstian A., McElduff P., D'Este C., Duffy D., and Attia J. A method for meta-analysis of molecular association studies. Stat Med 24 (2005) -1291
32. Higgins J.P., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539
33. Sterne J.A., and Egger M. Funnel plots for detecting bias in meta-analysis. guidelines on choice of axis. J Clin Epidemiol 54 (2001) 1046
34. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 315 (1997) -629
35. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) -1088
36. Shen S.W., Hu C.Y., Lin C.Y., Yang Y.C., and Hsieh R.P. Human leukocyte antigen polymorphisms in the Taiwanese population. J Formos Med Assoc (1999) 98-11
37. Lin M., Chu C.C., Chang S.L., Lee H.L., Loo J.H., Akaza T., Juji T., Ohashi J., and Tokunaga K. The origin of Minnan and Hakka the so-called "Taiwanese" inferred by HLA study. Tissue Antigens 57 (2001) -192
38. Glew S.S., Duggan-Keen M., Ghosh A.K., Ivinson A., Sinnott P., Davidson J., Dyer P.A., and Stern P.L. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum Immunol 37 (1993) -157
39. Duggan-Keen M.F., Keating P.J., Stevens F.R., Sinnott P., Snijders P.J., Walboomers J.M., Davidson S., Hunter R.D., Dyer P.A., and Stern P.L. Immunogenetic factors in HPV-associated cervical cancer. influence on disease progression. Eur J Immunogenet 23 (1996) -275
40. Allen M., Kalantari M., Ylitalo N., Pettersson B., Hagmar B., Scheibenpflug L., Johansson B., Petterson U., and Gyllensten U. HLA DQ-DR haplotype and susceptibility to cervical carcinoma. indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens (1996) 48-32
41. Odunsi K., Terry G., Ho L., Bell J., Cuzick J., and Ganesan T.S. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int J Cancer 67 (1996) -595
42. Helland A., Borresen A.L., Kristensen G., and Ronningen K.S. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix. relationship to human papillomavirus infection and prognosis. Cancer Epidemiol Biomarkers Prev 3 (1994) -479
43. Apple R.J., Erlich H.A., Klitz W., Manos M.M., Becker T.M., and Wheeler C.M. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 6 (1994) -157
44. Breitburd F., Ramoz N., Salmon J., and Orth G. HLA control in the progression of human papillomavirus infections. Semin Cancer Biol 7 (1996) -359
45. Egger M., and Smith G.D. Bias in location and selection of studies. Bmj (1998) 316-61
46. Stokkers P.C., Reitsma P.H., Tytgat G.N., and van Deventer S.J. HLA-DR and -DQ phenotypes in inflammatory bowel disease. a meta-analysis. Gut 45 (1999) -395